Drug Export; AtroventRegister (Ipratropium Bromide) Nasal Spray 0.03%, 10 Milliliter (mL) and 30 mL

الملخص

The Food and Drug Administration (FDA) is announcing that Boehringer Ingelheim Pharmaceuticals Inc., has filed an application requesting approval for the export of the human drug Atrovent (ipratropium bromide) Nasal Spray 0.03%, 10 mL and 30 mL to Canada.